Two minor NQO1 and NQO2 alleles predict poor response of breast cancer patients to adjuvant doxorubicin and cyclophosphamide therapy
Jamieson, David, Cresti, Nicola, Bray, Johanne, Sludden, Julieann, Griffin, Melanie J, Hawsawi, Nahed M, Famie, Eve, Mould, Emily V A, Verrill, Mark W, May, Felicity E B, Boddy, Alan V
Published in Pharmacogenetics and genomics (01.12.2011)
Published in Pharmacogenetics and genomics (01.12.2011)
Get more information
Journal Article